Use of smoothing splines for analysis of backscattered ultrasonic waveforms : application to monitoring of steroid treatment of dystrophic mice

Duchenne muscular dystrophy (DMD) is an X-linked genetic disease characterized by progressive weakness and wasting of skeletal and cardiac muscle; boys present with weakness by the age of 5 years and, if left untreated, are unable to walk without assistance by the age of 10 years. Therapy for DMD ha...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:IEEE transactions on ultrasonics, ferroelectrics, and frequency control. - 1986. - 58(2011), 11 vom: 13. Nov., Seite 2361-9
1. Verfasser: Hughes, Michael S (VerfasserIn)
Weitere Verfasser: Marsh, Jon N, Agyem, Kwesi F, McCarthy, John E, Maurizi, Brian N, Wickerhauser, Mladen Victor, Wallace, Kirk D, Lanza, Gregory M, Wickline, Samuel A
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2011
Zugriff auf das übergeordnete Werk:IEEE transactions on ultrasonics, ferroelectrics, and frequency control
Schlagworte:Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Anti-Inflammatory Agents Steroids
LEADER 01000caa a22002652 4500
001 NLM213040824
003 DE-627
005 20250213094426.0
007 cr uuu---uuuuu
008 231224s2011 xx |||||o 00| ||eng c
024 7 |a 10.1109/TUFFC.2011.2093  |2 doi 
028 5 2 |a pubmed25n0710.xml 
035 |a (DE-627)NLM213040824 
035 |a (NLM)22083769 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Hughes, Michael S  |e verfasserin  |4 aut 
245 1 0 |a Use of smoothing splines for analysis of backscattered ultrasonic waveforms  |b application to monitoring of steroid treatment of dystrophic mice 
264 1 |c 2011 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 28.03.2012 
500 |a Date Revised 21.10.2021 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Duchenne muscular dystrophy (DMD) is an X-linked genetic disease characterized by progressive weakness and wasting of skeletal and cardiac muscle; boys present with weakness by the age of 5 years and, if left untreated, are unable to walk without assistance by the age of 10 years. Therapy for DMD has been primarily palliative, with oral steroids emerging as a first-line approach even though this treatment has serious side-effects. Consequently, low-cost imaging technology suitable for improved diagnosis and treatment monitoring of DMD would be of great value, especially in remote and underserved areas. Previously, we reported use of the logarithm of the signal energy, log [E(f)], and a new method for ultrasound signal characterization using entropy, H(f), to monitor prednisolone treatment of skeletal muscle in a dystrophin-deficient mouse model. Three groups were studied: mdx mice treated with prednisolone, a control group of mdx mice treated with saline, and a control group of wild-type mice treated with saline. It was found that both log [E(f)] and H(f) were required to statistically differentiate the three groups. In the current study, we show that preprocessing of the raw ultrasound using optimal smoothing splines before computation of either log [E(f)] or a rapidly computable variant of Hf, denoted I(f,∞), permits delineation of all three groups by either metric alone. This opens the way to the ultimate goal of this study, which is identification and implementation of new diagnostically sensitive algorithms on the new generation of low-cost hand-held clinical ultrasonic imaging systems 
650 4 |a Journal Article 
650 4 |a Research Support, N.I.H., Extramural 
650 4 |a Research Support, U.S. Gov't, Non-P.H.S. 
650 7 |a Anti-Inflammatory Agents  |2 NLM 
650 7 |a Steroids  |2 NLM 
700 1 |a Marsh, Jon N  |e verfasserin  |4 aut 
700 1 |a Agyem, Kwesi F  |e verfasserin  |4 aut 
700 1 |a McCarthy, John E  |e verfasserin  |4 aut 
700 1 |a Maurizi, Brian N  |e verfasserin  |4 aut 
700 1 |a Wickerhauser, Mladen Victor  |e verfasserin  |4 aut 
700 1 |a Wallace, Kirk D  |e verfasserin  |4 aut 
700 1 |a Lanza, Gregory M  |e verfasserin  |4 aut 
700 1 |a Wickline, Samuel A  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t IEEE transactions on ultrasonics, ferroelectrics, and frequency control  |d 1986  |g 58(2011), 11 vom: 13. Nov., Seite 2361-9  |w (DE-627)NLM098181017  |x 1525-8955  |7 nnns 
773 1 8 |g volume:58  |g year:2011  |g number:11  |g day:13  |g month:11  |g pages:2361-9 
856 4 0 |u http://dx.doi.org/10.1109/TUFFC.2011.2093  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 58  |j 2011  |e 11  |b 13  |c 11  |h 2361-9